IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma

PURPOSE: Human interleukin-21 (IL-21) is a class I cytokine previously reported in clinical studies on immune responsive cancers. Here we report the effects of systemic IL-21 therapy on the immune system in two phase 1 trials with this novel cytokine. EXPERIMENTAL DESIGN: Recombinant IL-21 was admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Frederiksen, Klaus Stensgaard, Lundsgaard, Dorthe, Freeman, Jeremy A., Hughes, Steven D., Holm, Thomas L., Skrumsager, Birte K., Petri, Andreas, Hansen, Lasse T., McArthur, Grant A., Davis, Ian D., Skak, Kresten
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491425/
https://www.ncbi.nlm.nih.gov/pubmed/18286285
http://dx.doi.org/10.1007/s00262-008-0479-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491425/
https://www.ncbi.nlm.nih.gov/pubmed/18286285
http://dx.doi.org/10.1007/s00262-008-0479-4

Ejemplares similares